TRIPLICATE PRESCRIPTION PROGRAM (TPP)
REDUCING PRESCRIPTION DRUG MISUSE AND ABUSE
Established in 1986, the Triplicate Prescription program (TPP) monitors the use of certain drugs prone to misuse and abuse in Alberta. TPP is administered by CPSA in collaboration with partner organizations.
TPP collects prescribing and dispensing data for listed drugs.
When the data meet certain criteria, physicians and others involved in the care of the patient are alerted, provided with information and directed to resources that can support them in providing safe care.
Program Information for Prescribers
Registering as a prescriber with TPP
- Prescribers must register with TPP to prescribe any medication on the TPP medication list.
- Medical Residents must obtain approval from their program director prior to registering with TPP.
Re-ordering Triplicate pads
Email TPPinfo@cpsa.ab.ca or contact 1 800 561 3899 ext 4939. Include the following information with your request:
- Your registration number
- Your clinic’s complete address including postal code
- Phone number that is to be printed on the pads
- Complete address for shipping, if different.
Lost or stolen TPP forms
If your TPP pad or any of the forms are missing or stolen, you must contact the police and notify CPSA immediately. The prescriber should provide the following information to CPSA:
- Date of Theft or loss
- Triplicate Prescription number of the missing form(s) or pad(s)
- Name of the last patient prescribed a triplicate prescription
- The police file number and investigating constable’s name and phone number.
Program Information for Pharmacists
List of Stolen and Missing Triplicates
Pharmacists looking for the list of stolen or missing triplicates can access the list through the Alberta College of Pharmacists (login required) or contact TPP directly at TPPinfo@cpsa.ab.ca or call 1 800 561 3899 ext. 4939.
Prescribers with TPP Prescribing Restrictions
CPSA can impose prescribing conditions on physicians that restrict their prescriptive authority under certain situations. These listings and conditions are shown below:
|Beeharry||Raj||Restricted from prescribing any benzodiazepines, including chloral hydrate, zopiclone and other z-drugs unless the prescription is: a. Prescribed as an anticonvulsant; b. Prescribed to a patient for a maximum of two weeks in any three month period; or c. Supported by written direction or recommendation from a consult from a specialist or knowledgeable colleague. Restricted from prescribing narcotic analgesics (or any products containing Codeine) unless the prescription is: a. A narcotic analgesic prescribed to a patient with malignancy-related pain that is documented by a pathology report or consultant’s report; b. A narcotic analgesic prescribed to a patient with acute, non-malignant pain for a maximum of two weeks for any three-month period; or c. Supported by written direction or recommendation from a consult from a specialist or knowledgeable colleague|
|Collett||Franklin Dean||Prescribing restrictions apply. Prescribing restrictions for the following medications: Triplicate Prescription Program medications, anabolic steroids, methylphenidate, barbiturates, codeine containing drugs, amphetamine or amphetamine like appetite suppressants, benzodiazepines and other anxiolytics, hypnotics and sedatives, and muscle relaxants.|
|Datar||Sunil||Shall not prescribe, dispense or provide samples of any drug that is listed on the College’s Triplicate Prescription Program Product List, whether prescribed using the triplicate pad or otherwise monitored by the program, inclusive of codeine products, benzodiazepines and “Z Class Drugs”.|
|Gauri||Mohammed Ali||Restricted from prescribing triplicate prescriptions with the exception of opioid analgesics for malignancy-related pain documented by pathology report and/or consultant’s report.|
|Iwashkiw||Boris Michael||Restricted from prescribing any drugs on the Triplicate Prescription Program (and no products containing Codeine) or any benzodiazepines and other anxiolytics, hypnotics and sedatives including Chloral Hydrate, Zopiclone or other Z-Drugs.|
|Jackman||Kevin F.M.||Restricted from prescribing any benzodiazepines and other anxiolytics, hypnotics and sedatives including chloral hydrate, zopiclone and other z-drugs with the following exceptions: prescribed as an anticonvulsant. Restricted from prescribing any drugs on the Triplicate Prescription Program Product List (and no products containing Codeine or tramadol) with the following exceptions: Narcotic analgesics for patients with malignancy-related pain that is documented by a pathology report or consultant’s report and non-TPP Narcotic analgesics (Codeine or Tramadol) for patients with acute non-malignant pain for a maximum of one week for each patient in any three month period.|
|Krog||Pieter||Restricted from obtaining or using a triplicate prescription pad.|
|McAlpine||Brian Douglas||Restricted from prescribing triplicate medications.Restricted from prescribing stimulant medications or medications used in the treatment of Attention Deficit Disorder.|
|McDonald||Norman||Prescribing restrictions apply. Not initiate to current patients prescriptions for benzodiazepines and other anxiolytics, hypnotics and sedatives including chloral hydrate, zopiclone and other z-drugs with the following exceptions: a. unless prescribed as an anticonvulsant; b. for a maximum period of two weeks for each patient in any three month period. Not initiate to current patients prescriptions for opioid analgesics, including Codeine with the following exceptions: a. for the management of cancer pain or palliative care; b. for a maximum of two weeks for each patient in any three month period.|
|McPeak||Brian K.||Restricted from prescribing medications which require a triplicate prescription pad.|
|Mohamed||Ataher S||Restricted from prescribing any medication monitored by the Triplicate Prescription Program.|
|Moir||James Allan||Restricted from prescribing medications designated as part of the Triplicate Prescription Program.|
|Neu||S. Randall||Restricted from prescribing triplicate medication.|
|Rosenstock||Carl||Restricted from prescribing any benzodiazepines, including chloral hydrate, zopiclone and other z-drugs with the following exceptions: 1. Prescribed as an anticonvulsant; 2. Prescribed to a patient for a maximum of two weeks in any three month period; or 3. Supported by a direction or recommendation arising from a consult from a specialist or knowledgeable colleague. Restricted from prescribing any drugs on the Triplicate Prescription Program List (or any products containing Codeine) with the following exceptions: 1. A narcotic analgesic prescribed to a patient with malignancy-related pain that is documented by a pathology report or consultant’s report; 2. A narcotic analgesic prescribed to a patient with acute non-malignant pain for a maximum of two weeks for any three month period; or 3. Supported by a direction or recommendation arising from a consult from a specialist or knowledgeable colleague.|
|Thompson||Robert Douglas||Restricted from prescribing any medications which require a Triplicate Prescription pad.|
|Wachtler||Oswald||Prescribing restrictions apply. Prescribing restrictions on prescriptions for triplicate prescriptions, benzodiazepines, anxiolytics, sedatives including chloral hydrate and zopiclone.|
|White||Roger Tyler||Discontinue providing medications of potential abuse including triplicate program medications and benzodiazepines.|
|Workun||Shane Alex||Triplicate prescriptions for in-patient hospital or long-term patient for a maximum of two weeks.|
Following registration, you will receive a personalized triplicate prescription pad with a re-order form included in the prescription pads or email TPPinfo@cpsa.ab.ca, or phone 1-800-561-3899 ext. 4939. Use only TPP prescription forms to prescribe TPP medications and avoid disruption in patient care.
Note: Only two pads (100 prescriptions) may be ordered at one time.
Refer to Instructions for Using a Triplicate Prescription Pad (link to PDF to come as above). The prescriber retains the PRACTITIONER COPY (bottom). The top two parts of the form are used by the dispenser. The pharmacist or veterinarian clinic retains the PHARMACY COPY and forwards the CPSA COPY to the College of Physicians & Surgeons of Alberta (CPSA).
Prescribers should ensure the security of their TPP forms to avoid misuse by individuals seeking to improperly obtain TPP medications.
- TPP forms are personalized and must not be shared. The prescriber’s name, business address, and a unique prescriber identification number are imprinted on the pads. The unique prescriber identification number is NOT the prescriber’s registration or license number.
- When a prescriber retires, leaves practice, or leaves the province, unused TPP forms must be returned to the CPSA for proper destruction.
- Prescribers who have no fixed business address (e.g., locums) are issued special TPP forms that identify the prescriber’s name and unique prescriber identification number. When issuing a TPP prescription, these prescribers must enter on the form the name of the medical clinic/hospital/professional for whom the prescriber is working, address and a contact number (telephone or pager).
- LOST OR STOLEN TPP forms must be immediately reported to police and the CPSA. The CPSA will require the following information:
- Date of loss or theft
- TPP Prescription Number(s) of missing pad(s)
- Name of the last patient prescribed a TPP medication
- Police file number and investigating officer’s name and phone number
Click here for a downloadable sample patient treatment agreement and information on using the agreement to monitor the use of medications prescribed for chronic non-malignant pain conditions.
“Multi-doctoring” or “doctor shopping” is when a person seeks to obtain a prescription or a narcotic from a practitioner without informing the practitioner about every prescription or narcotic obtained by that person within the previous 30 days.
Both unlawful possession and obtaining multiple prescriptions for opioids and other prescription drugs, without proper disclosure, are criminal offences that can bring a fine of up to $1,000 or imprisonment for up to six months, or both, for a first offence (summary conviction). Penalties increase for subsequent convictions or possession of larger amounts (i.e. conviction for trafficking can bring life imprisonment).
For more information, refer to the Controlled Drugs and Substances Act, (1996, c. 19 C-38.8)
The triplicate form is considered part of the patient record. As such, the copy should be retained for the same period that a patient record must be maintained as per applicable legislation for your profession.
You should keep the prescriber’s copy within the patient’s record at your clinic. Refrain from leaving the form within the pad. Storing the copy within the pad can compromise patient confidentiality, especially in the case of loss or theft.
Your triplicate pad is issued to you as a prescriber. If you are moving practice, you should take your TPP pad with you and update the program at firstname.lastname@example.org.
- TPP Medication List
- Cannabis for Medical Purposes
- Sample Opioid Medication Treatment Agreement
- TPP Alberta – OME and DDD Conversion Factors
- TPP Atlas – The TPP Atlas provides an overview of provincial TPP medication utilization for the stated year.
- TPP Annual Report – The TPP annual report provides a comprehensive summary of program activities throughout the preceding year.
TPP News & Events
- MD Snapshot
- Access to valuable ADHD treatment now easier
- CAMH Opioid Dependence Treatment Course: For upcoming course dates, check the University of Calgary Cumming School of Medicine calendar
TPP Alberta is funded primarily by the provincial government and administered by the CPSA. TPP partners:
WE CAN HELP
Physicians, pharmacists and other healthcare providers
Contact Triplicate Prescription Program
1-800-561-3899 (in Canada) ext. 4939
The College does not provide a list of physicians prescribing specific medications.
Ed Jess, Director
Prescribing & Analytics